Company news
Waverley Pharma, Inc. news in 2020
Waverley Pharma, Inc.'s news releases, calls and decks from 2020, newest first.
Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United States
November 12, 2020
Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)
September 23, 2020
Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States
September 8, 2020
Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy
August 25, 2020
Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries
July 30, 2020
Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Synthetic Library of Chloroquine Analogs to Treat COVID-19
June 25, 2020
Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial Statements
April 28, 2020
Waverley Pharma Announces Appointment of New President and CEO
February 3, 2020
Waverley Pharma Announces Executive Leadership Changes
January 8, 2020